Evidence map›Paper›PMID 11777936›Full record

ArticleThe Journal of cell biology2002

Fyn tyrosine kinase is a downstream mediator of Rho/PRK2 function in keratinocyte cell-cell adhesion.

Enzo Calautti, Maddalena Grossi, Cristina Mammucari, Yumi Aoyama, Maria Pirro, Yoshitaka Ono, Jie Li, G Paolo Dotto

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 162 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Enzo CalauttiCutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129.
Maddalena Grossi
Cristina Mammucari
Yumi Aoyama
Maria Pirro
Yoshitaka Ono
Jie Li
G Paolo Dotto
Harvard University · USMassachusetts General Hospital · US

Funding

VIRAL SMALL RNPS--ROLES IN CELL TRANSFORMATIONP01CA016038 · NCI · YALE UNIVERSITY · PI DIMAIO, DANIEL C. · 1985 to 2020
$25.6M
GROWTH DIFFERENTIATION CONTROL IN PRIMARY KERATINOCYTES.R01AR039190 · NIAMS · YALE UNIVERSITY · PI DOTTO, GIAN-PAOLO · 1988 to 2021
$9.5M
KINASES AND EPITHELIAL DIFFERENTIATION CONTROLR01CA073796 · NCI · UNIVERSITY OF LAUSANNE · PI DOTTO, GIAN-PAOLO · 1998 to 2006
$2.0M
NCI NIH HHS CA16038NCI NIH HHS CA73796NCI NIH HHS P01 CA016038NCI NIH HHS R01 CA073796NIAMS NIH HHS AR39190NIAMS NIH HHS R01 AR039190
6 · The paper itself

Abstract

The Rho GTPase and Fyn tyrosine kinase have been implicated previously in positive control of keratinocyte cell-cell adhesion. Here, we show that Rho and Fyn operate along the same signaling pathway. Endogenous Rho activity increases in differentiating keratinocytes and is required for both Fyn kinase activation and increased tyrosine phosphorylation of beta- and gamma-catenin, which is associated with the establishment of keratinocyte cell-cell adhesion. Conversely, expression of constitutive active Rho is sufficient to promote cell-cell adhesion through a tyrosine kinase- and Fyn-dependent mechanism, trigger Fyn kinase activation, and induce tyrosine phosphorylation of beta- and gamma-catenin and p120ctn. The positive effects of activated Rho on cell-cell adhesion are not induced by an activated Rho mutant with defective binding to the serine/threonine PRK2/PKN kinases. Endogenous PRK2 kinase activity increases with keratinocyte differentiation, and, like activated Rho, increased PRK2 activity promotes keratinocyte cell-cell adhesion and induces tyrosine phosphorylation of beta- and gamma-catenin and Fyn kinase activation. Thus, these findings reveal a novel role of Fyn as a downstream mediator of Rho in control of keratinocyte cell-cell adhesion and implicate the PRK2 kinase, a direct Rho effector, as a link between Rho and Fyn activation.

Indexed as

Trans-ActivatorsActinsAnimalsbeta CateninCadherinsCalciumCell AdhesionCell DifferentiationCells, CulturedCytoskeletal ProteinsCytoskeletonDesmoplakinsEnzyme Activationgamma CateninHumansKeratinocytesActinsbeta CateninCadherinsCalciumCTNNB1 protein, humanCTNNB1 protein, mouseCytoskeletal ProteinsDesmoplakinsFYN protein, humanFyn protein, mousegamma CateninJUP protein, humanJup protein, mousePhosphotyrosineProtein Kinase Cprotein kinase NProto-Oncogene ProteinsProto-Oncogene Proteins c-fynProto-Oncogene Proteins pp60(c-src)rho GTP-Binding ProteinsTrans-Activators

Identifiers

PMID11777936
PMCPMC2173591
OpenAlexW2119486893

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.